Owens & Minor, Inc. Aktie News

RICHMOND, Va.--(BUSINESS WIRE)--Effective September 1, 2025, Apria and Byram, part of the Owens & Minor family, entered a new national provider agreement with Optum Health.

NEW YORK , Sept. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 22, to coincide with the quarterly rebalance.

Owens & Minor, Inc.'s disastrous performance, weak margins, and strategic missteps have eroded investor confidence and driven OMI stock down 70% in a year. The planned sale of its core Products & Healthcare Services business highlights severe financial distress, with all proceeds earmarked for debt reduction. Guidance was slashed dramatically, revealing ongoing operational weakness and a multi-...

Owens & Minor, Inc. (NYSE:OMI ) Q2 2025 Earnings Conference Call August 11, 2025 8:30 AM ET Company Participants Jacqueline Marcus - IR, Alpha IR Group LLC Edward A. Pesicka - President, CEO & Director Jonathan A.

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2025. In connection with a likely sale of the Company's Products & Healthcare Services segment, the results herein, unless otherwise noted, reflect the Company's continuing operations which primarily represent what was previously the Patient Direct segment and c...

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the second quarter of 2025 on Monday, August 11, 2025, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:30 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035,...

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today announced it has mutually agreed with Rotech Healthcare Holdings Inc. to terminate the previously announced acquisition. Under the terms of the merger agreement, Owens & Minor has paid $80 million to Rotech Healthcare. Owens & Minor will also redeem the $1 billion of notes issued in April 2025, which include a special mandato...

OMI is undervalued, with catalysts including FTC approval for the Rotech acquisition and a potential segment sale that could boost cash and reduce net debt. The company's share buybacks at $8.66 and recent acquisitions signal insider confidence, while OMI trades far below peer multiples and intrinsic value estimates. Strong free cash flow generation, successful debt refinancing, and a history o...